<p>The invention relates to the use of a cell death marker labelled with a wavelength- optimised label for identifying cell death in the eye. Suitable cell death markers are the Annexins and fragments and derivatives thereof. The invention also relates to a pharmaceutical composition comprising a cell death marker labelled with a wavelength- optimised label and a method for monitoring cell death in the eye using a cell death marker labelled with a wavelength-optimised label.</p>
申请公布号
WO2009077750(A1)
申请公布日期
2009.06.25
申请号
WO2008GB04156
申请日期
2008.12.15
申请人
UCL BUSINESS PLC;CORDEIRO, FRANCESCA;MOSS, STEPHEN;FITZKE, FREDERICK
发明人
CORDEIRO, FRANCESCA;MOSS, STEPHEN;FITZKE, FREDERICK